Show simple item record

dc.contributor.authorBerg, Erlend
dc.contributor.authorTegn, Nicolai Kloumann
dc.contributor.authorAbdelnoor, Michael
dc.contributor.authorRyalen, Pål Christie
dc.contributor.authorRøysland, Kjetil
dc.contributor.authorAaberge, Lars
dc.contributor.authorEek, Christian
dc.contributor.authorØie, Erik Harald
dc.contributor.authorJuliebø, Vibeke
dc.contributor.authorGjertsen, Erik
dc.contributor.authorRanhoff, Anette Hylen
dc.contributor.authorGullestad, Lars
dc.contributor.authorNordstrand, Njord
dc.contributor.authorBendz, Bjørn
dc.date.accessioned2024-03-11T09:19:57Z
dc.date.available2024-03-11T09:19:57Z
dc.date.created2023-11-15T11:16:31Z
dc.date.issued2023
dc.identifier.issn0735-1097
dc.identifier.urihttps://hdl.handle.net/11250/3121722
dc.description.abstractBackground Non–ST-segment elevation acute coronary syndrome (NSTE-ACS) is a frequent cause of hospital admission in older people, but clinical trials targeting this population are scarce. Objectives The After Eighty Study assessed the effect of an invasive vs a conservative treatment strategy in a very old population with NSTE-ACS. Methods Between 2010 and 2014, the investigators randomized 457 patients with NSTE-ACS aged ≥80 years (mean age 85 years) to an invasive strategy involving early coronary angiography with immediate evaluation for revascularization and optimal medical therapy or to a conservative strategy (ie, optimal medical therapy). The primary endpoint was a composite of myocardial infarction, need for urgent revascularization, stroke, and death. The long-term outcomes are presented. Results After a median follow up of 5.3 years, the invasive strategy was superior to the conservative strategy in the reduction of the primary endpoint (incidence rate ratio: 0.76; 95% CI: 0.63-0.93; P = 0.0057). The invasive strategy demonstrated a significant gain in event-free survival of 276 days (95% CI: 151-400 days; P = 0.0001) at 5 years and 337 days (95% CI: 123-550 days; P = 0.0001) at 10 years. These results were consistent across subgroups of patients with respect to major cardiovascular prognostic factors. Conclusions In patients aged ≥80 years with NSTE-ACS, the invasive strategy was superior to the conservative strategy in the reduction of composite events and demonstrated a significant gain in event-free survival. (The After Eighty Study: a randomized controlled trial; NCT01255540)en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleLong-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non–ST-Segment Elevation Acute Coronary Syndromesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1016/j.jacc.2023.09.809
dc.identifier.cristin2196957
dc.source.journalJournal of the American College of Cardiologyen_US
dc.source.pagenumber2021-2030en_US
dc.identifier.citationJournal of the American College of Cardiology. 2023, 82 (21), 2021-2030.en_US
dc.source.volume82en_US
dc.source.issue21en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal